Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 and the Endolysosomal System in Parkinson’s Disease
Madalynn L. Erb, Darren J. Moore
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1271-1291
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

The pathogenesis of Parkinson's disease
Huw R. Morris, Maria Grazia Spillantini, Carolyn M. Sue, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 293-304
Open Access | Times Cited: 281
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 92
Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 70
A STING–CASM–GABARAP pathway activates LRRK2 at lysosomes
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
The Journal of Cell Biology (2025) Vol. 224, Iss. 2
Open Access | Times Cited: 3
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
Thomas P Spargo, Chloe F. Sands, Isabella R. Juan, et al.
Cell Reports (2025), pp. 115355-115355
Open Access | Times Cited: 2
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Kai Zhang, Shiou Zhu, Jiamei Li, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3015-3034
Open Access | Times Cited: 92
LRRK2 recruitment, activity, and function in organelles
Luis Bonet‐Ponce, Mark Cookson
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 6871-6890
Open Access | Times Cited: 60
LRRK2 and Parkinson's disease: from genetics to targeted therapy
Yuri L. Sosero, Ziv Gan‐Or
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 6, pp. 850-864
Open Access | Times Cited: 31
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 27
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models
Matthew G Williamson, Marta Madureira, William McGuinness, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 18, pp. 2808-2821
Open Access | Times Cited: 23
Retromer-dependent lysosomal stress in Parkinson's disease
Dario R. Alessi, Peter J. Cullen, Mark Cookson, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 8
Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
Raja Elizabeth Estes, Bernice Lin, Arnav Khera, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 55
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Padmashri Naren, Anjali Cholkar, Suchita N. Kamble, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S399-S428
Open Access | Times Cited: 28
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
Alexi Nott, Inge R. Holtman
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Rubén Fernández‐Santiago, Manu Sharma
Ageing Research Reviews (2022) Vol. 79, pp. 101648-101648
Open Access | Times Cited: 23
α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson’s disease
Annie J. Zalon, Drew J. Quiriconi, Caleb Pitcairn, et al.
The Neuroscientist (2024) Vol. 30, Iss. 5, pp. 612-635
Closed Access | Times Cited: 5
LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 565-565
Open Access | Times Cited: 5
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Maxime Teixeira, Razan Sheta, Walid Idi, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1333-1333
Open Access | Times Cited: 31
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
Susanna Cogo, Franz Y. Ho, Elena Tosoni, et al.
Brain Research (2022) Vol. 1778, pp. 147781-147781
Open Access | Times Cited: 21
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
(2022)
Open Access | Times Cited: 20
Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6338-6338
Open Access | Times Cited: 12
Aging, cellular senescence and Parkinson's disease
Yue Ma, Madalynn Erb, Darren J. Moore
Journal of Parkinson s Disease (2025)
Open Access
Identification of plasma exosomal microRNAs and bioinformatics analysis of the microRNA-messenger RNA regulatory pathways in mice with status epilepticus
Wei Wang, Jian Yin
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top